Aberdeen Asset Management’s Elevance Health ELV Stock Holding History

Aberdeen Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$47.7M	Buy	253,614 +25,490	+11%	+$4.58M	0.16%	123
2017 Q1	$37.7M	Buy	228,124 +4,218	+2%	+$671K	0.13%	149
2016 Q4	$32.2M	Sell	223,906 -3,904	-2%	-$523K	0.12%	165
2016 Q3	$28.5M	Sell	227,810 -1,006	-0.4%	-$130K	0.1%	163
2016 Q2	$30.1M	Buy	228,816 +5,762	+3%	+$788K	0.11%	135
2016 Q1	$31M	Buy	223,054 +9,638	+5%	+$1.29M	0.11%	123
2015 Q4	$29.8M	Buy	213,416 +6,811	+3%	+$938K	0.1%	137
2015 Q3	$28.9M	Buy	206,605 +838	+0.4%	+$126K	0.1%	126
2015 Q2	$33.8M	Sell	205,767 -3,195	-2%	-$510K	0.1%	119
2015 Q1	$32.3M	Buy	208,962 +3,494	+2%	+$497K	0.09%	132
2014 Q4	$25.8M	Buy	205,468 +30,996	+18%	+$3.83M	0.06%	152
2014 Q3	$20.9M	Sell	174,472 -4,806	-3%	-$551K	0.05%	204
2014 Q2	$19.3M	Buy	179,278 +147,780	+469%	+$15.2M	0.04%	226
2014 Q1	$3.14M	Hold	31,498	–	–	0.01%	260
2013 Q4	$2.89M	Hold	31,498	–	–	0.01%	253
2013 Q3	$2.63M	Sell	31,498 -3,520	-10%	-$302K	0.01%	250
2013 Q2	$2.87M	Buy	+35,018	New	+$2.62M	0.01%	233

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aberdeen Asset Management's ELV Position: Q2 2017 in Review

Aberdeen Asset Management increased its Elevance Health (ELV) stake by 11% in Q2 2017, buying an estimated $4.58M and bringing the position to 253,614 shares worth $47.7M. The position accounts for 0.16% of the portfolio, ranked #123.

Aberdeen Asset Management first reported a position in ELV in Q2 2013 and has held it in 17 quarters since. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

Aberdeen Asset Management held 253,614 shares of Elevance Health worth $47.7M as of Q2 2017.
Aberdeen Asset Management bought 25,490 Elevance Health shares in Q2 2017, an estimated $4.58M.
Elevance Health made up 0.16% of Aberdeen Asset Management's portfolio in Q2 2017, its #123 holding.
Aberdeen Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 17 quarters since.
851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.